Holen Sie sich die Stockscreener-App
1.33
3.91%
0.05
Handel nachbörslich:
1.35
0.02
+1.50%
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
MAIA Biotechnology Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Continued Pipeline ProgressCommunity Buy Alerts - Newser
MAIA Biotechnology, Inc. 8-K Filing: Annual Meeting Results, Company Details, and NYSE American Listing - Minichart
MAIA Biotechnology Shareholders Back Board and Auditor Appointments - TipRanks
Maia Biotechnology shareholders re-elect directors and ratify auditor at annual meeting - Investing.com
MAIA Biotechnology (MAIA) investors back 2026 directors and auditor at meeting - Stock Titan
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - Yahoo Finance
MAIA Biotechnology (MAIA) Flat at $1.26 — Consolidation Continues 2026-05-18Beta Signals - newser.com
MAIA (NASDAQ: MAIA) Solas Capital and F. T. Golden report 7.1% ownership - Stock Titan
MAIA Biotechnology Ends ATM Stock Offering Agreement - TipRanks
Maia BiotechnologyTo Terminate At The Market Offering Agreement Effective May 23, 2026SEC Filing - TradingView
MAIA Biotechnology (MAIA) halts ATM share sales and terminates program - Stock Titan
MAIA (NYSE American) terminates ATM with H.C. Wainwright after $5.68M raised - Stock Titan
TradingKey - TradingKey
MAIA Biotechnology (NYSEAMERICAN:MAIA) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
MAIA Biotechnology (MAIA) delivers Q4 earnings beat, cutting losses by 32% as clinical pipeline advances.Market Expert Watchlist - Newser
MAIA Biotechnology, Inc. 1Q 2026: Net income $(6.37M), EPS $(0.14) — 10-Q Summary - TradingView
MAIA Biotechnology (MAIA) boosts cash with $33M raise as NSCLC trials advance - Stock Titan
MAIA Biotechnology | 424B5: Prospectus - Moomoo
Short Interest in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Rises By 23.0% - MarketBeat
MAIA Biotechnology (MAIA) Projected to Post Quarterly Earnings on Friday - MarketBeat
MAIA Biotechnology (MAIA) price target increased by 18.16% to 12.38 - MSN
MAIA Should I Buy - Intellectia AI
BREAKING: TRUMP JUST BOUGHT THIS STOCK! (01ajqP9sss) - fathomjournal.org
MAIA Biotechnology (MAIA) posts narrower Q4 2025 loss than analyst estimates, lifting shares 4.44 percent today.Pre Earnings - newser.com
MAIA Biotechnology | 8-K: Current report - Moomoo
MAIA Biotechnology (MAIA) Stock Ask Wall (Investor Interest) 2026-04-20Most Watched Stocks - Newser
MAIA Biotechnology opens first U.S. site for lung cancer trial By Investing.com - Investing.com Australia
MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Update - MarketBeat
MAIA Biotechnology opens first U.S. site for lung cancer trial - Investing.com
MAIA Expands THIO-101 Lung Cancer Trial in U.S. - TipRanks
MAIA Biotechnology activates first U.S. site for THIO-101 Phase 2 expansion, NIH funds $2.3M - TradingView
MAIA Biotechnology Activates First U.S. Site for THIO-101 Phase 2 Trial, Reporting Promising Efficacy in Advanced NSCLC Treatment - Quiver Quantitative
Form 8-KCurrent report - ADVFN
MAIA Biotechnology Activates First U.S. Site for Ongoing - GlobeNewswire
MAIA Biotechnology (MAIA) CEO awarded 800,000 stock options at $1.28 - Stock Titan
[Form 4] MAIA Biotechnology, Inc. Insider Trading Activity - Stock Titan
MAIA Biotechnology (MAIA) grants 30,000 stock options to finance head - Stock Titan
EPS Watch: How do insiders feel about MAIA Biotechnology IncMarket Movement Recap & Safe Capital Growth Plans - baoquankhu1.vn
Aug Drivers: How does MAIA Biotechnology Inc compare to its peersMarket Risk Summary & Real-Time Sentiment Analysis - baoquankhu1.vn
Value Recap: Is MAIA Biotechnology Inc trading at a discountLayoff News & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Short Covering: Is MAIA Biotechnology Inc stock forming a cup and handle2026 Sector Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Earnings Report: Is MAIA Biotechnology Inc stock forming a cup and handle - baoquankhu1.vn
Is MAIA Biotechnology (MAIA) Stock Slowing Down | Price at $1.25, Up 4.58%Triple EMA - Newser
Day Trade: What are the future prospects of MAIA Biotechnology IncBond Market & AI Optimized Trade Strategies - baoquankhu1.vn
MAIA Biotechnology Raises $33M to Fully Fund Pivotal Phase 3 Trial of Ateganosine for Advanced NSCLC Treatment - Minichart
Earnings Recap: Is MAIA Biotechnology Inc in a long term uptrend2026 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn
MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial - TipRanks
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy - The Manila Times
MAIA Biotechnology says $33M raise should fully fund pivotal Phase 3 trial of ateganosine - TradingView
MAIA (NYSE: MAIA) uses $33M raise to fund Phase 3 lung cancer study - Stock Titan
MAIA Biotechnology Expects Recent $33 Million Capital Raise - GlobeNewswire
MAIA Biotechnology (NYSE American: MAIA) plans 2026 virtual shareholder meeting, pay vote - Stock Titan
MAIA Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Is MAIA Biotechnology (MAIA) Stock Good for Long Term | Price at $1.29, Down 3.01%Trending Stock Ideas - Newser
MAIA Biotechnology Awards Executive Bonuses After Successful Financing - TipRanks
MAIA Biotechnology (NASDAQ: MAIA) director receives 27,258 stock options at $1.40 - Stock Titan
MAIA Biotechnology (MAIA) awards director 27,907 options at $1.40 - Stock Titan
MAIA (MAIA) director receives grant of 27,258 stock options - Stock Titan
MAIA Biotechnology (MAIA) director granted 33,748 stock options - Stock Titan
MAIA (MAIA) director receives 28,556 stock options at $1.40 strike - Stock Titan
MAIA Biotechnology (MAIA) awards cash bonuses after recent capital raise - Stock Titan
0.98%
0.12%
Kapitalisierung:
|
Volumen (24h):